Page last updated: 2024-10-26

diphenyleneiodonium and Lung Injury, Acute

diphenyleneiodonium has been researched along with Lung Injury, Acute in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research Excerpts

ExcerptRelevanceReference
" The aim of this study was to investigate the effects of diphenyleneiodonium (DPI), a NOX inhibitor, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in a rat model."7.91Protective effects of diphenyleneiodonium, an NADPH oxidase inhibitor, on lipopolysaccharide-induced acute lung injury. ( Kim, CH; Kim, SH; Kim, SK; Kim, SY; Lee, SH; Rho, SJ; Song, SH; Yoo, JY, 2019)
" The aim of this study was to investigate the effects of diphenyleneiodonium (DPI), a NOX inhibitor, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in a rat model."3.91Protective effects of diphenyleneiodonium, an NADPH oxidase inhibitor, on lipopolysaccharide-induced acute lung injury. ( Kim, CH; Kim, SH; Kim, SK; Kim, SY; Lee, SH; Rho, SJ; Song, SH; Yoo, JY, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SK1
Rho, SJ1
Kim, SH1
Kim, SY1
Song, SH1
Yoo, JY1
Kim, CH1
Lee, SH1

Other Studies

1 other study available for diphenyleneiodonium and Lung Injury, Acute

ArticleYear
Protective effects of diphenyleneiodonium, an NADPH oxidase inhibitor, on lipopolysaccharide-induced acute lung injury.
    Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:2

    Topics: Acute Lung Injury; Animals; Cytokines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulat

2019